NASDAQ | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GERN | Geron Corporation | Healthcare | Biotechnology | 2.92% |
| ACRV | Acrivon Therapeutics Inc. Common Stock | Healthcare | Biotechnology | 2.4% |
| ELVN | Enliven Therapeutics Inc. | Healthcare | Biotechnology | 2.09% |
| JANX | Janux Therapeutics Inc | Healthcare | Biotechnology | 1.79% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 1.78% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 1.76% |
| NUVB | Nuvation Bio Inc | Healthcare | Biotechnology | 1.72% |
| CGEM | Cullinan Oncology LLC | Healthcare | Biotechnology | 1.63% |
| HCM | HUTCHMED DRC | Healthcare | Drug Manufacturers - Specialty & Generic | 1.62% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.58% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.56% |
| TSVT | 2Seventy Bio Inc | Healthcare | Biotechnology | 1.55% |
| RAIN | Rain Therapeutics Inc | Healthcare | Biotechnology | 1.52% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.49% |
| NK | NantKwest Inc | Healthcare | Biotechnology | 1.49% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.48% |
| MOR | MorphoSys AG ADR | Healthcare | Biotechnology | 1.45% |
| MRUS | Merus BV | Healthcare | Biotechnology | 1.45% |
| LYEL | Lyell Immunopharma Inc | Healthcare | Biotechnology | 1.43% |
| YMAB | Y mAbs Therapeutics | Healthcare | Biotechnology | 1.42% |
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio of U.S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts ("ADRs") with a market capitalization of more than $250 million. The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. Under normal circumstances, at least 80% of the fund"s total assets will be invested in the component securities of the index.